BLFS Biolife Solutions Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BLFS

Price (delayed)

$37.74

Market cap

$1.85B

P/E Ratio

31.71

Dividend/share

N/A

EPS

$1.19

Enterprise value

$1.84B

?
Relative Growth: Rel. Growth: 91
Relative Strength: Rel. Strength: 93
Relative Valuation: Rel. Valuation: 52
Relative Profitability: Rel. Profitability: 77

BioLife Solutions, Inc. (BioLife) is a life sciences tools provider. The Company's product offerings include bio-preservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing ...

Highlights
BLFS's quick ratio has soared by 106% year-on-year and by 30% since the previous quarter
The company's revenue rose by 25% YoY and by 5% QoQ
The debt has declined by 34% year-on-year but it has grown by 6% since the previous quarter
BLFS's gross margin is down by 4.2% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.biolifesolutions.com
Peers: CE ENTA

Key stats

What are the main financial stats of BLFS

BLFS stock price

How has the Biolife Solutions stock price performed over time
Intraday
-0.87%
1 week
4.51%
1 month
1.73%
1 year
52.48%
YTD
56.08%
QTD
33.64%

Financial performance

How have Biolife Solutions's revenue and profit performed over time
Revenue
$102.82M
Gross profit
$65.68M
Operating income
$2.98M
Net income
$57.98M
Gross margin
63.9%
Net margin
56.4%
BLFS's operating income has soared by 120% QoQ and by 118% YoY
The operating margin has soared by 119% from the previous quarter and by 114% YoY
The company's revenue rose by 25% YoY and by 5% QoQ
The company's gross profit rose by 20% YoY and by 4.9% QoQ

Price vs fundamentals

How does BLFS's price correlate with its fundamentals

Growth

What is Biolife Solutions's growth rate over time

Valuation

What is Biolife Solutions stock price valuation
BLFS P/E details
P/E
31.71
P/B
4.39
P/S
17.94
EV/EBIT
150.31
EV/EBITDA
95.75
EV/Sales
17.87
BLFS's price to book (P/B) is 64% higher than its 5-year quarterly average of 2.7 and 43% higher than its last 4 quarters average of 3.1
The equity has grown by 21% YoY and by 13% from the previous quarter
The P/S is 48% higher than the last 4 quarters average of 12.2 and 40% higher than the 5-year quarterly average of 12.9
The company's revenue rose by 25% YoY and by 5% QoQ

Efficiency

How efficient is Biolife Solutions business performance

Dividends

What is BLFS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BLFS.

Financial health

How did Biolife Solutions financials performed over time
BLFS's current ratio has surged by 119% year-on-year and by 33% since the previous quarter
BLFS's quick ratio has soared by 106% year-on-year and by 30% since the previous quarter
The debt is 96% smaller than the equity
Biolife Solutions's debt to equity has decreased by 43% YoY
The debt has declined by 34% year-on-year but it has grown by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.